Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 109 companies set new 52-week lows.
Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher
US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%.
35 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday.
Mid-Morning Market Update: Markets Mostly Higher; Dow Rises 100 Points
US stocks opened mostly higher this morning, with the Dow Jones adding more than 100 points on Tuesday.
Pulse Biosciences Says On Feb, 5 Received Letter From FDA In Which FDA Stated It Did Not Believe Co. Provided Sufficient Clinical Evidence To Support Expanded Indication For Use To Expand CellFX System’s Current Labeling
Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced an update to its recent
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
Pulse Biosciences Q2 EPS $(0.58) Beats $(0.75) Estimate
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.75) by 22.67 percent. This is a 9.43 percent decrease over losses of $(0.53) per share from
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.